Desai Arjun JJ 4
Research Summary
AI-generated summary
Clene (CLNN) Director Arjun Desai Receives Option Award
What Happened Arjun Desai, a director of Clene Inc. (CLNN), received an option award for 3,168 shares of common stock on February 19, 2026. The Form 4 reports the grant as a derivative acquisition (code A) with an exercise price of $4.73 per share; exercising all options would cost roughly $14,985. The options vest immediately upon grant.
Key Details
- Transaction date: 2026-02-19 (reported on Form 4 filed 2026-02-20).
- Grant type: Stock option award (derivative); acquisition reported at $0.00 (grant), exercise price $4.73/share.
- Shares/options granted: 3,168 options.
- Vesting: Options vest immediately (per footnote).
- Shares owned after transaction: Not specified in the excerpt of the filing — see the full Form 4 for post-transaction beneficial ownership.
- Filing timeliness: Filed the next day (appears timely under Form 4 reporting rules).
Context This was an option grant (an award), not a market purchase or sale — it does not represent immediate buying or selling of shares. Because the options vest immediately, Desai can exercise them at $4.73 per share (paying the exercise price) if he chooses; the filing does not indicate any immediate exercise or sale. Option grants are a common form of executive/director compensation and do not by themselves indicate a change in insider sentiment.